Literature DB >> 15340263

A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancer.

Fred H Menko1, Gertjan L Kaspers, Gerrit A Meijer, Kathleen Claes, Johanna M van Hagen, Johan J P Gille.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant condition due to heterozygous germline mutations in DNA mismatch repair genes, in particular MLH1, MSH2 and MSH6. Recently, a syndrome was recognized in which children develop haematological malignancies, solid tumours and signs of neurofibromatosis type 1 due to bi-allelic MMR gene mutations in MLH1, MSH2 and PMS2. Here we describe the child of healthy consanguineous parents who had café-au-lait spots, oligodendroglioma, and rectal cancer. The patient was homozygous for the MSH6 mutation c.3386_3388delGTG in exon 5 which has a predicted pathogenic effect. Germline NF1 gene mutation testing was negative. The rectal tumour showed microsatellite instability and absence of MSH6 staining, whereas the brain tumour was MSI stable and showed normal immunohistochemical expression of MSH6. Apparently, not only MLH1, MSH2 and PMS2, but also MSH6 is involved in the syndrome of childhood cancer and signs of neurofibromatosis type 1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340263     DOI: 10.1023/B:FAME.0000039893.19289.18

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  23 in total

1.  The role of hPMS1 and hPMS2 in predisposing to colorectal cancer.

Authors:  T Liu; H Yan; S Kuismanen; A Percesepe; M L Bisgaard; M Pedroni; P Benatti; K W Kinzler; B Vogelstein; M Ponz de Leon; P Peltomäki; A Lindblom
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

2.  The role of hMLH3 in familial colorectal cancer.

Authors:  Hong-Xu Liu; Xiao-Lei Zhou; Tao Liu; Barbro Werelius; Gudrun Lindmark; Niklas Dahl; Annika Lindblom
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

3.  Extensive somatic microsatellite mutations in normal human tissue.

Authors:  S Vilkki; J L Tsao; A Loukola; M Pöyhönen; O Vierimaa; R Herva; L A Aaltonen; D Shibata
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

4.  Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.

Authors:  J M Friedman; P H Birch
Journal:  Am J Med Genet       Date:  1997-05-16

5.  Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.

Authors:  M De Rosa; C Fasano; L Panariello; M I Scarano; G Belli; A Iannelli; F Ciciliano; P Izzo
Journal:  Oncogene       Date:  2000-03-23       Impact factor: 9.867

6.  Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice.

Authors:  D H Gutmann; E Winkeler; O Kabbarah; N Hedrick; S Dudley; P J Goodfellow; R M Liskay
Journal:  Oncogene       Date:  2003-07-17       Impact factor: 9.867

7.  Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC?

Authors:  J D Trimbath; G M Petersen; S H Erdman; M Ferre; M C Luce; F M Giardiello
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

8.  Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation.

Authors:  Steven Gallinger; Melyssa Aronson; Katayoon Shayan; Elyanne M Ratcliffe; Justin T Gerstle; Patricia C Parkin; Heidi Rothenmund; Marina Croitoru; Ewa Baumann; Peter R Durie; Rosanna Weksberg; Aaron Pollett; Robert H Riddell; Bo Y Ngan; Ernest Cutz; Alain E Lagarde; Helen S L Chan
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

9.  Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1.

Authors:  M D Ricciardone; T Ozçelik; B Cevher; H Ozdağ; M Tuncer; A Gürgey; O Uzunalimoğlu; H Cetinkaya; A Tanyeli; E Erken; M Oztürk
Journal:  Cancer Res       Date:  1999-01-15       Impact factor: 12.701

10.  Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.

Authors:  Qing Wang; Gilles Montmain; Eric Ruano; Meena Upadhyaya; Sandra Dudley; R Michael Liskay; Stephen N Thibodeau; Alain Puisieux
Journal:  Hum Genet       Date:  2002-11-21       Impact factor: 4.132

View more
  19 in total

1.  Back to the future: proceedings from the 2010 NF Conference.

Authors:  Susan M Huson; Maria T Acosta; Allan J Belzberg; Andre Bernards; Jonathan Chernoff; Karen Cichowski; D Gareth Evans; Rosalie E Ferner; Marco Giovannini; Bruce R Korf; Robert Listernick; Kathryn N North; Roger J Packer; Luis F Parada; Juha Peltonen; Vijaya Ramesh; Karlyne M Reilly; John W Risner; Elizabeth K Schorry; Meena Upadhyaya; David H Viskochil; Yuan Zhu; Kim Hunter-Schaedle; Filippo G Giancotti
Journal:  Am J Med Genet A       Date:  2010-12-22       Impact factor: 2.802

2.  Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.

Authors:  Daniel P Cahill; Kymberly K Levine; Rebecca A Betensky; Patrick J Codd; Candice A Romany; Linsey B Reavie; Tracy T Batchelor; P Andrew Futreal; Michael R Stratton; William T Curry; A John Iafrate; David N Louis
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

Review 3.  Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations.

Authors:  Prathap Bandipalliam
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.

Authors:  Juana V Martín-López; Ysamar Barrios; Vicente Medina-Arana; Miguel Andújar; Sanghee Lee; Liya Gu; Guo-Min Li; Josef Rüschoff; Eduardo Salido; Richard Fishel
Journal:  Carcinogenesis       Date:  2012-06-27       Impact factor: 4.944

5.  Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis.

Authors:  E Zeynep Erson-Omay; Ahmet Okay Çağlayan; Nikolaus Schultz; Nils Weinhold; S Bülent Omay; Koray Özduman; Yavuz Köksal; Jie Li; Akdes Serin Harmancı; Victoria Clark; Geneive Carrión-Grant; Jacob Baranoski; Caner Çağlar; Tanyeri Barak; Süleyman Coşkun; Burçin Baran; Doğan Köse; Jia Sun; Mehmet Bakırcıoğlu; Jennifer Moliterno Günel; M Necmettin Pamir; Ketu Mishra-Gorur; Kaya Bilguvar; Katsuhito Yasuno; Alexander Vortmeyer; Anita J Huttner; Chris Sander; Murat Günel
Journal:  Neuro Oncol       Date:  2015-03-03       Impact factor: 12.300

6.  Gastrointestinal Findings in the Largest Series of Patients With Hereditary Biallelic Mismatch Repair Deficiency Syndrome: Report from the International Consortium.

Authors:  Melyssa Aronson; Steven Gallinger; Zane Cohen; Shlomi Cohen; Rina Dvir; Ronit Elhasid; Hagit N Baris; Revital Kariv; Harriet Druker; Helen Chan; Simon C Ling; Paul Kortan; Spring Holter; Kara Semotiuk; David Malkin; Roula Farah; Alain Sayad; Brandie Heald; Matthew F Kalady; Lynette S Penney; Andrea L Rideout; Mohsin Rashid; Linda Hasadsri; Pavel Pichurin; Douglas Riegert-Johnson; Brittany Campbell; Doua Bakry; Hala Al-Rimawi; Qasim Kholaif Alharbi; Musa Alharbi; Ashraf Shamvil; Uri Tabori; Carol Durno
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

7.  Association of MSH6 mutation with glioma susceptibility, drug resistance and progression.

Authors:  Chaoran Xie; Hansong Sheng; Nu Zhang; Shiting Li; Xiangyu Wei; Xuesheng Zheng
Journal:  Mol Clin Oncol       Date:  2016-05-20

8.  An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.

Authors:  Melanie H Kucherlapati; Kyeryoung Lee; Andrew A Nguyen; Alan B Clark; Harry Hou; Andrew Rosulek; Hua Li; Kan Yang; Kunhua Fan; Martin Lipkin; Roderick T Bronson; Linda Jelicks; Thomas A Kunkel; Raju Kucherlapati; Winfried Edelmann
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

Review 9.  Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?

Authors:  Katharina Wimmer; Julia Etzler
Journal:  Hum Genet       Date:  2008-08-18       Impact factor: 4.132

10.  Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum.

Authors:  Rein P Stulp; Johanna C Herkert; Arend Karrenbeld; Bart Mol; Yvonne J Vos; Rolf H Sijmons
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.